The muscle pathology report at that time was “Inclusion body myositis with lipid deposition.” In 2015, we performed genetic examination and found two heterozygous mutations in the PNPLA2 gene, which led to the diagnosis of neutral lipodeposition with myopathy. This evidence concerns the gene PNPLA2 and inclusion body myositis.